Leheny A. Rachel's Form 4/A amendment
AmendedCalciMedica, Inc. (CALC) · filed Jun 5, 2023
- Accession no.
- 0001209191-23-034642
- Filed
- Jun 5, 2023
- Trade date
- May 16, 2023
- Filing delay
- 20 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 18, 2023
This filing lists 1 non-derivative transaction. Open-market purchases total $2.70K. It was filed 20 days after the trade.
This amendment replaces 0001209191-23-030778 (filed May 18, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leheny A. RachelCIK 0001484729 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $2.70F1 | +$2,700 | 1,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The weighted average purchase price for the transaction reported was $2.698, and the range of prices were between $2.68 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Referenced by the price of 1 transaction in Table I.
Remarks
On May 18, 2023, the reporting person filed a Form 4 which inadvertently omitted the purchase of shares of the Issuer's Common Stock by her spouse which is reported in this amendment.